HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
81 hedge funds and large institutions have $61.5M invested in HilleVax in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 30 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
7% more funds holding
Funds holding: 76 → 81 (+5)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.92% less ownership
Funds ownership: 86% → 84.08% (-1.9%)
31% less capital invested
Capital invested by funds: $88.7M → $61.5M (-$27.2M)
33% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
Trium Capital
London,
United Kingdom
|
+$699K |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$197K |
| 3 |
Two Sigma Advisers
New York
|
+$113K |
| 4 |
Two Sigma Investments
New York
|
+$65K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$57.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$475K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$452K |
| 3 |
JP Morgan Chase
New York
|
-$294K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$245K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$178K |
HLVX Hedge Fund Activity: Q1 2025 in Review
81 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2025, worth a combined $61.5M — down 31% from $88.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new HLVX positions and 6 closed out — a net gain of 5 holders — while 20 added to existing stakes and 30 trimmed.
The largest buyer was Trium Capital, opening a new position worth an estimated $699K. The largest seller was Millennium Management, cutting an estimated $475K.
- 81 institutional investors held HilleVax (HLVX) as of Q1 2025, up from 76 in Q4 2024.
- Funds reported $61.5M of HilleVax stock for Q1 2025, down 31% quarter-over-quarter.
- 11 funds opened new HilleVax positions in Q1 2025 and 6 closed out, a net change of +5 holders.
- The largest HilleVax buyer in Q1 2025 was Trium Capital, an estimated $699K added.
- The largest HilleVax seller in Q1 2025 was Millennium Management, an estimated $475K sold.
Based on aggregated 13F filings for Q1 2025.